New drug targets in the context of cancer refer to molecules or pathways that can be specifically targeted by therapeutics to inhibit the growth and spread of cancer cells. With advances in genomics and proteomics, researchers are identifying novel targets that could potentially improve the efficacy of cancer treatments while minimizing side effects.
